Renee Carroll
Consejero General en ACER THERAPEUTICS INC. .
Perfil
Renee Carroll is currently the Vice President-Regulatory Affairs at Acer Therapeutics, Inc. She has an undergraduate degree from Merrimack College and a graduate degree from Worcester Polytechnic Institute.
Cargos activos de Renee Carroll
| Empresas | Cargo | Inicio |
|---|---|---|
| ACER THERAPEUTICS INC. | Consejero General | 01/01/2020 |
Formación de Renee Carroll.
| Worcester Polytechnic Institute | Graduate Degree |
| Merrimack College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Renee Carroll
